| Literature DB >> 34266342 |
Dongxiao Han1, Lianqiang Qu2, Liuquan Sun3,4, Yanqing Sun5.
Abstract
In HIV vaccine efficacy trials, mark-specific hazards models have important applications and can be used to evaluate the strain-specific vaccine efficacy. Additive hazards models have been widely used in practice, especially when continuous covariates are present. In this article, we conduct variable selection for a mark-specific additive hazards model. The proposed method is based on an estimating equation with the first derivative of the adaptive LASSO penalty function. The asymptotic properties of the resulting estimators are established. The finite sample behavior of the proposed estimators is evaluated through simulation studies, and an application to a dataset from the first HIV vaccine efficacy trial is provided.Entities:
Keywords: Adaptive LASSO; additive hazards model; competing risks; continuous mark; mark-specific vaccine effects; survival data
Mesh:
Substances:
Year: 2021 PMID: 34266342 PMCID: PMC9140222 DOI: 10.1177/09622802211023957
Source DB: PubMed Journal: Stat Methods Med Res ISSN: 0962-2802 Impact factor: 2.494